Human B lymphocytes activated by Epstein-Barr virus (EBV) or by mitogens suppress mitogen-induced immunoglobulin production.
Open Access
- 1 May 1981
- journal article
- research article
- Published by Oxford University Press (OUP) in The Journal of Immunology
- Vol. 126 (5) , 1810-1813
- https://doi.org/10.4049/jimmunol.126.5.1810
Abstract
Polyclonal activation of human B lymphocytes by LPS or protein A, alone or in combination or by Epstein-Barr virus (EBV), generates suppressive conditions that inhibit the response of human B lymphocytes to pokeweed mitogen (PWM), measured by the induction of immunoglobulin-secreting cells (PFC). Moreover, EBV-transformed B cell lines of normal or neoplastic (Burkitt lymphoma) origin also suppressed the PWM-induced immunoglobulin production of normal B cells. Cell separation experiments have shown that mitogen activated autologous B cells stimulate suppressor T cells in a similar way as B cell-derived lymphoblastoid cell lines. The significance of this phenomenon is considered in relation to the escape of the activating microorganism or virus from immune control and the occurrence of network interactions within the immune system.This publication has 3 references indexed in Scilit:
- Terminal differentiation of human promyelocytic leukemia cells induced by dimethyl sulfoxide and other polar compounds.Proceedings of the National Academy of Sciences, 1978
- GROUP-SPECIFIC HUMAN GRANULOCYTE ANTIGENS ON A CHRONIC MYELOGENOUS LEUKEMIA CELL LINE WITH A PHILADELPHIA CHROMOSOME MARKER1977
- Morphological and Virological Investigations on Cultured Burkitt Tumor Lymphoblasts (Strain Raji)2JNCI Journal of the National Cancer Institute, 1966